Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
07/12/2006 | CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
07/12/2006 | CN1802154A Pyridine N-oxides as antiviral agents |
07/12/2006 | CN1801359A Novel use of dithienylethene compounds |
07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
07/12/2006 | CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production |
07/12/2006 | CN1263751C Novel compounds |
07/12/2006 | CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid |
07/12/2006 | CN1263746C Pyridazinone derivatives |
07/12/2006 | CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels |
07/11/2006 | US7074945 Metal alkoxide taxane derivatives |
07/11/2006 | US7074935 Multistage process with acylation of amine as anesthetics |
07/11/2006 | US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds |
07/11/2006 | US7074826 R-NSAID esters and their use |
07/11/2006 | US7074819 Benzopyran or thiobenzopyran derivatives |
07/11/2006 | US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
07/11/2006 | US7074789 Kinase inhibitors |
07/11/2006 | US7074788 Antidiabetic agents; liver disorders; cardiovascular disorders; dietetics |
07/11/2006 | US7074785 Δ1-pyrrolines used as pesticides |
07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |
07/11/2006 | CA2285548C Nicotinamide derivatives |
07/11/2006 | CA2274074C Novel compounds with analgesic effect |
07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
07/11/2006 | CA2244870C N,n-disubstituted amic acid derivatives |
07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
07/11/2006 | CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
07/06/2006 | WO2006071958A1 Compounds useful as chemokine receptor antagonists |
07/06/2006 | WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound |
07/06/2006 | WO2006070001A1 Substituted indole ligands for the orl-1 receptor |
07/06/2006 | WO2006069946A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments |
07/06/2006 | WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
07/06/2006 | WO2006069788A1 Organic compounds |
07/06/2006 | WO2006069776A1 5-ht7 receptor antagonists |
07/06/2006 | WO2006069775A1 5-ht7 receptor antagonists |
07/06/2006 | WO2006069767A1 Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
07/06/2006 | WO2006069441A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
07/06/2006 | WO2006052893A3 Substituted pyrrolidone compounds as ep4 agonists |
07/06/2006 | WO2006050389A3 Pyridazine compounds, compositions and methods |
07/06/2006 | WO2006047415A3 FACTOR Xa COMPOUNDS |
07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
07/06/2006 | US20060149071 Hydrolyzing the ester group of an alkylated 4-amino-4-carboxyamino-piperidine compound and treating the piperidine hydrolysis product with a hydride to produce a 4-hydroxymethyl-piperidine; method requires fewer steps and produces a greater yield of product than known methods; synthetic opioids |
07/06/2006 | US20060149059 Phthalazinone derivatives |
07/06/2006 | US20060148881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-Benzodioxan |
07/06/2006 | US20060148879 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases |
07/06/2006 | US20060148876 Nr3b1 nuclear receptor binding 3-substituted pyrazoles |
07/06/2006 | US20060148872 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one |
07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
07/06/2006 | US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
07/06/2006 | US20060148845 In which a pyrrole ring is directly bonded to a 6,5-condensed ring system, such as a benzimidazole, imidazopyridine or imidazopyrimidine system; especially effective against drug resistant bacteria such as MRSA, PRSP, or VRE |
07/06/2006 | US20060148817 Pyrazole compounds |
07/06/2006 | US20060148812 4-cyano-1H-imidazole-2-carboxylic acid {2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl}-amide; protein tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
07/06/2006 | US20060148809 For the therapy of deleterious neurological complaints; anxiolytic agents;cognitive disorders; good affinity as ligands for the alpha 2 and or alpha 3 and or alpha 5 subunit of the human GABAA receptor; 3-(6-Phenylpyridazin-4-yl)thiophene-2-carboxylic Acid Methyl Ester |
07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
07/06/2006 | US20060148791 Glutamate receptor antagonists |
07/06/2006 | DE112004001675T5 Dendrimerverbindung und diese verwendendes organisches lumineszierendes Element Dendrimerverbindung and this-use organic luminescent element |
07/06/2006 | DE10248876B4 Verfahren zur Herstellung linearer organischer Oligomere A process for preparing linear organic oligomers |
07/06/2006 | DE102004062544A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel New substituted pyrrolidinones, their preparation and their Verewendung as medicaments |
07/06/2006 | DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines |
07/06/2006 | DE102004061748A1 Azetidin-substituierte Pyrazoline Azetidine-substituted pyrazolines |
07/06/2006 | DE102004061747A1 Thiophen-substituierte Pyrazoline Thiophene-substituted pyrazolines |
07/06/2006 | CA2592858A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
07/06/2006 | CA2592131A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments |
07/06/2006 | CA2591201A1 5-ht7 receptor antagonists |
07/06/2006 | CA2590666A1 5-ht7 receptor antagonists |
07/06/2006 | CA2587348A1 Organic compounds |
07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
07/05/2006 | EP1676844A1 5-HT7 receptor antagonists |
07/05/2006 | EP1676841A1 Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments |
07/05/2006 | EP1676840A1 5-HT7 Receptor antagonists |
07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
07/05/2006 | EP1675849A1 Benzimidazolyl derivatives |
07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
07/05/2006 | EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
07/05/2006 | EP1675832A1 Heterocyclyl compounds |
07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
07/05/2006 | EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
07/05/2006 | EP1225894B1 Fab i inhibitors |
07/05/2006 | CN1798738A Biaryl substituted pyrazoles as sodium channel blockers |
07/05/2006 | CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases |
07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
07/04/2006 | US7071220 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents |
07/04/2006 | US7071216 Anticancer agents |
07/04/2006 | US7071213 Cannabinoid receptor ligands |
07/04/2006 | US7071208 β3 Adrenergic agonists |
07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
07/04/2006 | US7071184 Protease inhibitors |
07/04/2006 | US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
06/29/2006 | WO2006069275A1 Tricyclic delta-opioid modulators |
06/29/2006 | WO2006069196A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
06/29/2006 | WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
06/29/2006 | WO2006067428A2 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
06/29/2006 | WO2006067414A2 Glycine transport inhibitors |